American Cancer Society, Inc. Extramural Grants
|
|
|
- Marlene Philomena Nichols
- 5 years ago
- Views:
Transcription
1 Page: 1 Institutional Research Grant (IRG) IRG Weber, Jason D., PhD Department of Internal Medicine Institutional Research Grant 01/01/ /31/2021 $360,000 Summary IRG Total Number of Grants: 1 Total Amount Awarded: $360,000
2 Page: 2 Mentored Research Scholar Grants in Applied and Clinical Research (MRSG) MRSG Peterson, Lindsay L., MD MENTOR: Colditz, Graham A., MD Department of Medicine The Role of Advanced Glycation End-Products in Breast Cancer Prognosis 01/01/ /31/2022 $581,000 Summary MRSG Total Number of Grants: 1 Total Amount Awarded: $581,000
3 Page: 3 Postdoctoral Fellowship (PF) PF Hwang, Priscilla, PhD MENTOR: Longmore, Gregory, MD Department of Oncology Microenvironment Cues Alter Leader Cell Development in Collective Migration 12/31/2020 $163,500 PF Nickless, Andrew, PhD MENTOR: Maher, Christopher, PhD Department of Medical Oncology Understanding the rrole of Onco- IncRNA-3 in Colorectal Cancer Metastasis 07/01/ /30/2021 $163,500 PF Pehrsson, Erica C., PhD MENTOR: Wang, Ting, PhD Department of Genetics Activated Transposable Elements as Novel Treatment Targets in NSCLC 12/31/2020 $163,500 Summary PF Total Number of Grants: 3 Total Amount Awarded: $490,500
4 Page: 4 Research Scholar Grant (RSG) RSG Cheng, Kun, PhD University of Missouri, Kansas City Department of Pharmaceutical Sciences Kansas City, MO Targeted Delivery of IKBKE sirna for Breast Cancer Therapy 07/01/ /30/2019 Funds ended 06/30/18 $525,000 RSG Lim, Kian-Huat, MD, PhD Department of Internal Medicine IRAK4 As A Novel Immunotherapeutic Target In Pancreatic Cancer 12/31/2021 $660,000 RSG Liu, Ying, MD, PhD Washington University School of Medicine Department of Surgery Disparities in Adherence to Adjuvant Therapy for DCIS and Outcomes 07/01/ /30/2021 Funds ended 06/29/21 $570,000 RSG Madison, Blair, PhD Department of Medicine Delineating a Pathway of Colorectal Cancer Downstream of Let-7 micrornas 01/01/ /31/2022 RSG Maher, Christopher, PhD Department of Medical Oncology Genomic Analysis of mccal1: Epigenetic Regulator of Colon Cancer Metastasis 07/01/ /30/2021 RSG Mosammaparast, Nima, MD, PhD Department of Pathology and Immunology Molecular Characterization of a Novel Alkylation Damage Signaling Pathway 01/01/ /31/2022 RSG Schuettpelz, Laura, MD, PhD Department of Pediatrics - Hematology/Oncology Role of TLR2 Signaling in the Transformation of MDS 12/31/2021 RSG Tripathy, Sandeep, MD, PhD Department of Medicine The Role of Natural Killer Cell Tolerance in their Response to Tumors 01/01/ /31/2019
5 Page: 5 RSG Wang, Ting, PhD Department of Genetics Epigenetic Control of Transposable Element Derived Enhancers in Cancer 07/01/ /30/2019 Funds ended 06/30/18 Summary RSG Total Number of Grants: 9 Total Amount Awarded: $6,507,000
6 Page: 6 Research Scholar Grant - Insurance (RSGI) RSGI Politi, Mary, PhD Department of Surgery Supporting Cancer Survivors Health Insurance Marketplace Decisions 07/01/ /30/2020 $706,000 Summary RSGI Total Number of Grants: 1 Total Amount Awarded: $706,000
7 Page: 7 Summary Grants in Effect for North Division, Missouri State Total Number of Grants: Total Amount Awarded: 15 $8,644,500
American Cancer Society, Inc. Extramural Grants
Page: 1 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP-17-124-01 Ranney, Lori, MSN MENTOR: Foote, Jane, EdD, MSN, RN Winona State University MN Graduate Scholarship in Cancer Nursing Practice
American Cancer Society, Inc. Extramural Grants
Page: 1 Doctoral Degree Scholarship in Cancer Nursing (DSCN) DSCN-17-079-01 Beckmann, Nicole, MSN MENTOR: Foster-Akard, Terrah L., PhD, RN, CPNP Vanderbilt University School of Nursing Parent Posttraumatic
American Cancer Society, Inc. Extramural Grants
Page: 1 Clinical Research Professorship (CRP) CRP-14-112-06 Chinnaiyan, Arul M., MD, PhD Department of Pathology and Urology Developing A Precision Medicine Framework for Cancer Patients 07/01/2014 $400,000
American Cancer Society, Inc. Extramural Grants
Page: 1 Cancer Control Career Development Award for Primary Care Physicians (CCCDA) CCCDA-14-013-01 Cole, Allison M., MD MENTOR: Baldwin, Laura-Mae, MD, MPH Department of Family Medicine Improving Colorectal
American Cancer Society, Inc. Extramural Grants
Page: 1 Doctoral Degree Scholarship in Cancer Nursing (DSCN) DSCN-17-226-01 Croson, Elizabeth, MSN MENTOR: Jones, Randy, PhD Department of Nursing Extended Adherence to Adjuvant Endocrine Therapy in Breast
American Cancer Society, Inc. Extramural Grants
Page: 1 Graduate Scholarships in Cancer (GSCNP) GSCNP-17-127-01 Conover, Rosabelle, BS MENTOR: Lazenby, Mark, PhD Department of Acute Care and Health Systems GSCNP-17-122-01 Desmond, Andrea J., BS MENTOR:
American Cancer Society, Inc. Extramural Grants
Page: 1 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP-16-128-01 Suarez, Stephanie N., BSN MENTOR: Tofthagen, Cindy, PhD, ARNP University of South Florida College of Nursing Graduate Scholarship
American Cancer Society, Inc. Extramural Grants
Page: 1 Doctoral Training Grant in Oncology Social Work (DSW) DSW-16-070-01 Smith, Lisa C., MSSW MENTOR: Kayser, Karen, PhD University of Louisville Research Foundation, Inc. Kent School of Social Work
American Cancer Society, Inc. Extramural Grants
Page: 1 Institutional Research Grant (IRG) IRG-16-184-56 Richer, Jennifer, PhD Department of Pathology Institutional Research Grant 12/31/2019 $510,000 Summary IRG Total Number of Grants: 1 Total Amount
American Cancer Society, Inc. Extramural Grants
Page: 1 Cancer Control Career Development Award for Primary Care Physicians (CCCDA) CCCDA-17-100-01 Kieber-Emmons, Autumn, MD MENTOR: Miller, William, MD, MA Lehigh Valley Hospital Department of Family
Siteman Investment Program (SIP) Awardees
Siteman Investment Program (SIP) Awardees The Siteman Investment Program is designed to award pilot funding to faculty investigators to support pioneering cancer research and produce data to leverage external
American Cancer Society, Inc. Extramural Grants
Page: 1 Doctoral Degree Scholarship in Cancer Nursing (DSCN) DSCN-16-064-01 Mann, Tara K., BSN MENTOR: Bailey, Donald (Chip) E., PhD, RN, FAAN Investigating Cognitive, Affective/Sleep Symptoms in Interleukin-2
NEWLY AWARDED RESEARCH AND HEALTH PROFESSIONAL TRAINING GRANTS
NEWLY AWARDED RESEARCH AND HEALTH PROFESSIONAL TRAINING GRANTS SUMMARY OF GRANTS APPROVED FOR FUNDING BY THE COUNCIL FOR EXTRAMURAL GRANTS AMENDED Post - Council Resolution September 14 15, The following
Racial/Ethnic Disparities in Second Breast Lesions after DCIS. Graham A. Colditz, MD DrPH Kevin Garza Ying Liu, MD PhD Rosy Luo, PhD Yu Tao, PhD
Racial/Ethnic Disparities in Second Breast Lesions after DCIS Graham A. Colditz, MD DrPH Kevin Garza Ying Liu, MD PhD Rosy Luo, PhD Yu Tao, PhD Why DCIS? DCIS over 45,000 cases per year SEER 18 Cancer
American Cancer Society Research Programs
American Cancer Society Research Programs The American Cancer Society dedicates more money to cancer research than any other private, not-for-profit, non-government funder of cancer research in the United
American Cancer Society, Inc. Extramural Grants
Page: 1 Cancer Control Career Development Award for Primary Care Physicians (CCCDA) CCCDA-17-100-01 Kieber-Emmons, Autumn, MD MENTOR: Miller, William, MD, MA Lehigh Valley Hospital Department of Family
Immune Checkpoints in the Tumor Environment:
Immune Checkpoints in the Tumor Environment: Novel Targets and the Clinical Promise of Combined Immunotherapies Monday, 28 October 2013 07.00 08.00 (AM) Parkside Ballroom B, Convention Centre Level 1 Phosphatidylserine
Research: Biography: Education:
Research: I study how treatment decisions are made during clinical encounters between patients newly diagnosed with cancer and their clinicians. My research pinpoints the factors that drive patient treatment
UCI. Anti-Cancer Challenge Impact report. #weareanticancer
UCI Anti-Cancer Challenge 2017 Impact report #weareanticancer Your support of the UCI Anti-Cancer Challenge is planting the seeds from which UCI research will grow to improve cancer therapies! As Orange
What I learned at MD Anderson Cancer Center. Showa University Department of Breast Surgical Oncology Hiroko Masuda MD.,PhD.
What I learned at MD Anderson Cancer Center Showa University Department of Breast Surgical Oncology Hiroko Masuda MD.,PhD. My Oncology Dream Award New nationwide competition in Japan among oncology professionals,
American College of Surgeons Clinical Research Program
1 American College of Surgeons Clinical Research Program Kelly K. Hunt, MD Program Director ACS CLINICAL RESEARCH PROGRAM EDUCATION COMMITTEE AGENDA Friday, May 15, 2015 8 am 10 am Education Committee
Affiliate Highlight: Fellow Gains New Perspective on the Impact of Breast Cancer Research
Page 1 of 5 Share Past Issues Komen Research Updates 2013 ASCO Annual Meeting, Exciting Research Grantee Announcements, and more! Table of Contents: Affiliate Highlight: Fellow Gains New Perspective on
HEMATOLOGY AND ONCOLOGY
x THE POWER OF HEMATOLOGY AND ONCOLOGY Experts. Experience. Execution. A Deeper Dive into Hematology and Oncology Medpace supports our sponsors who are advancing new anti-cancer therapies by providing
2017 Internship Directory: Summer Research Experience Program in Oncology- PA Student Applicants (6 pages)
Dhyan Chandra, PhD Pharmacology and Therapeutics /Dhyan-Chandra Role of Mitochondria in Cancer Prevention and Therapy The main focus of our research is to understand the molecular basis of therapy resistance
Lailea J Noel, PhD. 1 Washington Square North, Room G-04 New York, NY Phone:
Lailea J Noel, PhD 1 Washington Square North, Room G-04 New York, NY 10003-6654 Phone: 212-992-9217 lailea.noel@nyu.edu CURRENT POSITION 2016-Present RESEARCH Assistant Professor New York University Silver
New Biological and Immunological Therapies for Cancer
New Biological and Immunological Therapies for Cancer Sant P. Chawla, M.D., FRACP The Sarcoma Oncology Center, Santa Monica CA 90403 7 th International Conference on Drug Discovery &Therapy 1 Promising
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives
2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,
Slide 1. Slide 2. Slide 3 History of Nurse Navigator
Slide 1 The Nurse Navigators role in Early Stage Breast Cancer, and Development of Tailored Treatment Plan Laura Ochoa, RN, ANP-BC, Ph.D. Slide 2 Barnes Jewish Hospital at Washington University Slide 3
Applying current knowledge to accelerate cancer prevention: what is preventable and how?
Applying current knowledge to accelerate cancer prevention: what is preventable and how? UICC: World Cancer Congress Montreal Aug 29, 2012 Graham A Colditz, MD DrPH Niess-Gain Professor Conflict of interest
2018 Internship Directory: High School Summer Research Experience Program in Cancer Science (10 pages)
2018 Internship Directory: High School Summer Mentor area(s) Internship Boyko Atanassov Dept. of Pharmacology and Therapeutics /Boyko-Atanassov cellular biology Defining the functions of Ubiquitin Specific
Financial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO
Review and Impact of the NCDB PUF Moderator: Sandra Wong, MD, MS, FACS, FASCO Financial Disclosure I do not have personal financial relationships with any commercial interests Learning Objectives At the
We want to save patients with severe cancer and autoimmune diseases Entering clinical phase with our lead antibody CAN04 to our proprietary target
We want to save patients with severe cancer and autoimmune diseases Entering clinical phase with our lead antibody CAN04 to our proprietary target Göran Forsberg, CEO 1 Safe Harbour Statement The following
The Growing Landscape of Palliative Care
The Growing Landscape of Palliative Care Jeannine M. Brant, PhD, APRN, AOCN, FAAN Scientist, Billings Clinic PI, Montana Cancer Consortium Assistant Affiliate Professor, Montana State University Health
CSQI BACKGROUNDER What is The Cancer Quality Council of Ontario (CQCO)? What does CQCO do? What is the Cancer System Quality Index?
CSQI BACKGROUNDER What is The Cancer Quality Council of Ontario (CQCO)? Established in 2002 by the Ministry of Health and Long-Term Care (MOHLTC), the Cancer Quality Council of Ontario (CQCO) is an arm
Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program
Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program Joxel Garcia, MD, MBA Executive Director, Cancer Prevention and Control Platform Member, Moon Shots Program Leadership Team The
Genetic Services in St. Louis
Genetic Services in St. Louis Dr. Kathy Grange Genetics and Genomic Medicine Department of Pediatrics Washington University School of Medicine St. Louis, Missouri Founded: 1764 City population: 318,069
THE PATIENT VOICE IN CHINA:
6 th Asia-Pacific Conference, 2014 Issue Panel, IP5 THE PATIENT VOICE IN CHINA: WHAT IS THE WEIGHT OF PROs IN THE REIMBURSEMENT AND ACCESS DECISIONS OF PAYERS TODAY? GfK 2014 1 Stephen Potts Regional Lead,
Curriculum Vitae Hui Yuan, MD
Curriculum Vitae Hui Yuan, MD Current Position: Associate Professor Department of Saint Louis University Health Sciences Center Education: 1/1978 12/1982 M.D. in Medicine Postgraduate Training: 6/1984
Frontiers in PREVENTION. Research November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA
N I N T H A N N UA L A A C R I N T E R N AT I O N A L CO N F E R E N C E Frontiers in CANCER PREVENTION PROGRAM AND PROCEEDINGS November 7-10, 2010 Pennsylvania Convention Center Philadelphia, PA Continuing
Examining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database
Examining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database Taylor Seaton, MS Cancer Genomics Epidemiologist MDHHS Cancer Genomics Program: Lifecourse
Cancer Science nd International Conference on Oncology & Cancer Science. August 06-08, 2018 Berlin, Germany. Hosting Organization
Cancer Science 2018 2nd International Conference on Oncology & Cancer Science August 06-08, 2018 Berlin, Germany Hosting Organization Invitation Cenetri Publishing Group takes keen delectation and highly
We want to save patients with severe cancer and autoimmune diseases Entering clinical phase with our lead antibody CAN04 to our proprietary target
We want to save patients with severe cancer and autoimmune diseases Entering clinical phase with our lead antibody CAN04 to our proprietary target Göran Forsberg, CEO 1 Safe Harbour Statement The following
Epigenetic Advancements in Cancer
Epigenetic Advancements in Cancer Manoj K. Mishra Kumar S. Bishnupuri Editors Epigenetic Advancements in Cancer Editors Manoj K. Mishra Department of Biological Sciences Alabama State University Montgomery,
NCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017
NCI Cancer Moonshot Christine Siemon National Cancer Institute, NIH November 30, 2017 Presidential Memo 2016 Overall Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening
Early Age Onset Colorectal Cancer. New York. Saturday, March 21. EAO-CRC 2015 THE NATION S FIRST ANNUAL
Are Pleased to Jointly Sponsor THE NATION S FIRST ANNUAL Early Age Onset Colorectal Cancer S U M M I T Saturday, March 21 CONFERENCE LOCATION Memorial Sloan Kettering Cancer Center ROCKEFELLER RESEARCH
8/26/17 ONCOLOGY NURSING: WHAT IS ALL THE BUZZ AROUND NAVIGATION, SURVIVORSHIP AND DISTRESS SCREENING IN ONCOLOGY? WELCOME AND DISCLOSURES OBJECTIVES:
ONCOLOGY NURSING: WHAT IS ALL THE BUZZ AROUND NAVIGATION, SURVIVORSHIP AND DISTRESS SCREENING IN ONCOLOGY? 2nd Annual Ellis Fischel Cancer Symposium: Holistic Approach to Cancer Care August 25-26, 2017
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives
2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North
THE IMPORTANCE OF COMORBIDITY TO CANCER CARE AND STATISTICS AMERICAN CANCER SOCIETY PRESENTATION COPYRIGHT NOTICE
THE IMPORTANCE OF COMORBIDITY TO CANCER CARE AND STATISTICS AMERICAN CANCER SOCIETY PRESENTATION COPYRIGHT NOTICE Washington University grants permission to use and reproduce the The Importance of Comorbidity
Indiana University Hematology Oncology Fellows Research Interest
Coming into fellowship, my interest was in thoracic oncology. I was interested in targeted therapy in lung cancer and immunotherapy. My current research project is looking into combining immunotherapy
Synergistic combinations of targeted immunotherapy to combat cancer
Synergistic combinations of targeted immunotherapy to combat cancer Myung Ah Lee, M.D., Ph. D Division of Medical Oncology, Hepato-biliary pancreatic cancer center Seoul St. Mary s hospital, The Catholic
Jason Luke, MD, FACP Assistant Professor of Medicine University of Chicago, USA BRIEF INTRODUCTION
SPEAKERS BIOGRAPHY Jason Luke, MD, FACP Assistant Professor of Medicine University of Chicago, USA Jason Luke, MD, is an Assistant Professor of Medicine at University of Chicago where he specializes in
CCOP Clinical Trials Contributions and Challenges
CCOP Clinical Trials Contributions and Challenges Stephen S. Grubbs, M.D. Delaware Christiana Care CCOP Helen F. Graham Cancer Center National Cancer Policy Forum July 1, 2008 NCI Community Clinical Oncology
Dr Graeme Suthers: The genetic basis of cancer
Dr Graeme Suthers: The genetic basis of cancer Dr Suthers is the head of the Familial Cancer Unit at the Women s and Children s hospital. He will begin the evening with an introduction to cancer and its
Dr Sylvie Lambert, RN, PhD
Is it the most frequent unmet supportive care needs that predict caregivers anxiety and depression? Results from Australia s Partners and Caregivers Longitudinal Well-being Study Dr Sylvie Lambert, RN,
Original Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk in a Chinese Han population
Int J Clin Exp Med 2014;7(12):5832-5836 www.ijcem.com /ISSN:1940-5901/IJCEM0002117 Original Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk
High Impact Cancer Research Program
High Impact Cancer Research Program Advanced training in methods and conduct of clinical research APPLY AT HMS.HARVARD.EDU/HICR Dear Colleagues: Challenging problems. New strategies for success. Cross-disciplinary
ONCO-HU TM MICE FOR IMMUNOTHERAPEUTIC DRUG DISCOVERY. Brian W. Soper, Ph.D. Senior Technical Information Scientist
ONCO-HU TM MICE FOR IMMUNOTHERAPEUTIC DRUG DISCOVERY Brian W. Soper, Ph.D. Senior Technical Information Scientist Presentation Outline Capabilities Humanization Hu-NSG TM versus Hu-NSG TM -SGM3 Immuno-oncology
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC 20037 October 19-21, 2016 Wednesday, October 19, 2016 7:30 8:30 AM Registration
Update on Colorectal Cancer: Integrating the Host Immune Response 3 rd Emirates Surgical Pathology Conference 15 December 2017 Dubai, UAE
Update on Colorectal Cancer: Integrating the Host Immune Response 3 rd Emirates Surgical Pathology Conference 15 December 2017 Dubai, UAE Martine McManus, MD, FCAP Pathology & Laboratory Medicine Institute
Cost and Consequence: Trying to balance affordability and adherence
Cost and Consequence: Trying to balance affordability and adherence A James 1, J Hunleth 1, S Smith, 1 K Gilbert 2, D Bowen 3 1 Washington University in St Louis, 2 St Louis University, 3 University of
Exosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study
GBCC 2017: ABS-0017 Exosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study Soo Jung Lee 1, Jeeyeon Lee 2, Jin Hyang Jung 2, Ho Yong Park 2, Chan Hyeong Lee 3, Pyong
Overview for today. NSG and NSG -SGM3 are a proven platform. A growing list of drugs have shown translationally relevant response
1 Overview for today NSG and NSG -SGM3 are a proven platform A growing list of drugs have shown translationally relevant response Targeted therapeutics and anti-angiogenesis drugs show their expected response
PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION
PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION ROTATION TITLE Outpatient Adult Oncology PURPOSE The outpatient oncology service will provide the PGY-2 resident with the opportunity to further develop and
2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
Colorectal Cancer Screening in Washington State
Colorectal Cancer Screening in Washington State Susie Dade, Deputy Director, Washington Health Alliance March 25, 2016 Colorectal Cancer Roundtable Outline About the Alliance How we re doing in Washington
Latest Press Release. woman roasted over fireoman roasted
corp@stantec.com Latest Press Release woman roasted over fireoman roasted S So, if your cancer started in your lung and has spread to your bones, the areas of cancer in the bone are made up of lung cancer
Implementing international training programs for oncology research development
Implementing international training programs for oncology research development Kenneth S. Cohen, M.D. Assistant Professor of Medicine Program Director, Adult Hematology/Oncology Fellowship Program Section
C3: Cancer, Care and Comorbidity
C3: Cancer, Care and Comorbidity Symposium April 2014 Comorbidity: Why do we care? is common among cancer patients. has a major impact on patients. has a major impact on health services. Is an important
SCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017
Friday 1 st September 1300h 1400h Lunch (arrival, registration at conference foyer, coffee and sponsors exhibition) 1400h 1420h Prof Robert Jones Welcome/Announcements 1430h 1600h Parallel sessions: Lung
The 100,000 Genomes Project
The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England
Shelileah R. Newman. Certifications. Education. Work history. Board Certified. Licensure. Undergraduate / Bachelor of Science.
Shelileah R. Newman Certifications Board Certified Certified by The American Board of Radiology, 2009 Licensure North Carolina - Full and Unrestricted MD License, Number 2004-01566. Florida - Full and
Biology Based Cancer Interception
Biology Based Cancer Interception Waun Ki Hong, M.D. American Cancer Society Professor Former Head Division of Cancer Medicine UT MD Anderson Cancer Center Disclosures SAB : Janssen,Medimmune,Molecular
Clinical MOOK Lung Cancer - Epidemiology Discovery Diagnosis And Treatment ( ) (2005) ISBN: [Japanese Import]
![Clinical MOOK Lung Cancer - Epidemiology Discovery Diagnosis And Treatment ( ) (2005) ISBN: [Japanese Import]](/thumbs/89/98234020.jpg "Clinical MOOK Lung Cancer - Epidemiology Discovery Diagnosis And Treatment ( ) (2005) ISBN: [Japanese Import]")
Clinical MOOK Lung Cancer - Epidemiology Discovery Diagnosis And Treatment (2004-2005) (2005) ISBN: 4884126149 [Japanese Import] If you are looking for a ebook Clinical MOOK lung cancer - epidemiology
Understanding and Improving Quality of Cancer Care in Diverse Underserved Populations
Understanding and Improving Quality of Cancer Care in Diverse Underserved Populations Stephanie B Wheeler, PhD MPH Department of Health Policy & Management Overview Research Interests CDC-Special Interest
Targeting tumour associated macrophages in anti-cancer therapies. Annamaria Gal Seminar Series on Drug Discovery Budapest 5 January 2018
Targeting tumour associated macrophages in anti-cancer therapies Annamaria Gal Seminar Series on Drug Discovery Budapest 5 January 2018 Macrophages: Professional phagocytes of the myeloid lineage APC,
BIOMEDICAL SCIENCES GRADUATE PROGRAM SPRING 2017
THE OHIO STATE UNIVERSITY BIOMEDICAL SCIENCES GRADUATE PROGRAM SPRING 2017 Grant Foglesong PhD Candidate Lifestyle Improvements Enhance Metabolic Function and Mitigate Breast Cancer Progression March 20
The American Cancer Society National Quality of Life Survey for Caregivers
The American Cancer Society National Quality of Life Survey for Caregivers Rachel S. Cannady Strategic Director, Cancer Caregiver Support Atlanta, GA Agenda Definition and prevalence of cancer survivorship
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development MicroTek Training Center Washington, DC October 17 19, 2018
Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development MicroTek Training Center Washington, DC October 17 19, 2018 Wednesday, October 17, 2018 8:00 8:30 AM Registration and Continental
Welcome to Oncology as a Nurse Practitioner!
Welcome to Oncology as a Nurse Practitioner! As a nurse practitioner in cancer care there are many resources that can help orient you to the care of the patient and family with cancer. The members of the
Early Age Onset Colorectal Cancer. New York. Saturday, March EAO-CRC 2015 THE NATION S FIRST ANNUAL
Are Pleased to Jointly Sponsor THE NATION S FIRST ANNUAL Early Age Onset Colorectal Cancer S U M M I T Saturday, March 21 CONFERENCE LOCATION Memorial Sloan Kettering Cancer Center ROCKEFELLER RESEARCH
CONTROLLING THE IMMUNE RESPONSE IN GI CANCERS
CONTROLLING THE IMMUNE RESPONSE IN GI CANCERS Christopher Heery, MD Head, Clinical Trials Group Laboratory of Tumor Immunology and Biology National Cancer Institute Bethesda, MD Tumor Immunology Overview
Hampton Roads Oncology Update 2019:
Hampton Roads Oncology Update 2019: New Advances in Gastrointestinal Cancers SATURDAY, JULY 27, 2019 7:00 AM 1:45 PM Marriott at City Center Newport News, Virginia 5 AMA PRA Category 1 Credits EVMS Eastern
Genetic testing for hereditary cancer. An overview for healthcare providers
Genetic testing for hereditary cancer An overview for healthcare providers Specimen requirements Whole blood Two 4.5 ml EDTA tubes (lavender top) Please wait at least 2 weeks after a packed cell/platelet
Understanding and Optimizing Treatment of Triple Negative Breast Cancer
Understanding and Optimizing Treatment of Triple Negative Breast Cancer Edith Peterson Mitchell, MD, FACP Clinical Professor of Medicine and Medical Oncology Program Leader, Gastrointestinal Oncology Department
Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc
1 Personalized Medicine Disruptive Technology? David Logan Senior Vice President, Commercial Genomic Health Inc Safe Harbor Statement This presentation contains forward-looking statements within the meaning
2013 Oncology Pharmacy Specialty Recertification Home Study Syllabus Learning Objectives
2013 Oncology Pharmacy Specialty Recertification Home Study Syllabus Learning Objectives Breast Cancer Chad Barnett, Pharm.D., BCOP Clinical Pharmacy Specialist The University of Texas M.D. Anderson Cancer
MICHELLE C. GATES SIU School of Medicine Department of Psychiatry P.O. Box 19677, Springfield, IL
MICHELLE C. GATES SIU School of Medicine Department of Psychiatry P.O. Box 19677, Springfield, IL 62794-9677 217-545-3935 EDUCATION Fellowship Onco-Psychology Program 08/14-08/15 Department of Psychiatry
Houston January 27, 2018
Houston January 27, 2018 Brian Brewer Cancer Research Institute WELCOME Our Host A special thank you for hosting the Immunotherapy Patient Summit Our Sponsors This event is made possible with generous
Public Health Democracy: U.S. and Global Health Disparities in Breast Cancer
Public Health Democracy: U.S. and Global Health Disparities in Breast Cancer Doris Browne, MD, MPH Woodrow Wilson Public Policy Scholar Breast and Gynecologic Cancer Research Group NCI, Division of Cancer
SUSAN G. KOMEN ST. LOUIS EXECUTIVE SUMMARY
SUSAN G. KOMEN ST. LOUIS EXECUTIVE SUMMARY Acknowledgments The Community Profile Report could not have been accomplished without the exceptional work, effort, time and commitment from many people involved
KAISER PERMANENTE ANNUAL CANCER REPORT 2016 MEDICAL CENTER SAN FRANCISCO THE PERMANENTE MEDICAL GROUP COMMISSION ON CANCER COMMITTEE DECEMBER 2016
1 KAISER PERMANENTE ANNUAL CANCER REPORT 2016 SAN FRANCISCO MEDICAL CENTER THE PERMANENTE MEDICAL GROUP COMMISSION ON CANCER COMMITTEE DECEMBER 2016 2 OUR MISSION IS SIMPLE: Support our specialists in
Armstrong, Bruce (Prof.)
Presenter: Armstrong, Bruce (Prof.) Title of Lecture: Cancer Control Research COMMONWEALTH OF AUSTRALIA Copyright Regulations 1969 WARNING This material has been reproduced and communicated to you by or
Public Reporting of Outcomes 2016
Public Reporting of Outcomes 2016 The Genesis Cancer Care Institute, Genesis Medical Center, Davenport, Iowa is an American College of Surgeon s Commission on Cancer (CoC) accredited program. The CoC is
Chronic Diseases, Injury Kansas Department of Health and Environment, Bureau of Health Promotion
Chronic Diseases, Injury Kansas Department of Health and Environment, Bureau of Health Promotion Topeka, Kansas Assignment Description The CDC/CSTE applied chronic disease epidemiology fellow position
Trends in Lung Cancer Morbidity and Mortality
Trends in Lung Cancer Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Program Services Division November 2014 Table of Contents Trends in Lung Cancer Morbidity
How to improve the reliability of Single Arm Trials
Workshop on Single Arm Trials in Oncology Products EMA, London, June 30, 2016 How to improve the reliability of Single Arm Trials Paolo Bruzzi Clinical Epidemiology Unit IRCCS San Martino-IST - National
Diet, Exercise and Nutrition in Cancer Prevention and Survivorship
Diet, Exercise and Nutrition in Cancer Prevention and Survivorship Jessica Clague DeHart, PhD, MPH Visiting Professor, Department of Medical Oncology, City of Hope Assistant Professor, Claremont Graduate
Copyright. Tocagen Inc. Lead Product Candidate: Toca 511 & Toca FC Preclinical Overview
Lead Product Candidate: Toca 511 & Toca FC Preclinical Overview Toca 511, delivers CD prodrug activator gene selectively to cancer cells Regulatory genes Structural RRV genes CD gene Regulatory genes Toca
Identification and Verification of Translational Biomarkers for Patient Stratification and Precision Medicine
Biomarkers for Patients Stratification and Precision Medicine -- Cancer and Beyond AAPS National Biotechnology Conference, Boston on May 16-18, 2016 Identification and Verification of Translational Biomarkers
K Award Career Development Plan
K Award Career Development Plan Guidance & Tips Anil Wali, PhD July 19, 2017 Outline 1. Candidate s Background 2. Career Goals and Objectives 3. Candidate s Plan for Career Development/Training Activities